GLUT1 expression has an important relationship with 18FGD-PET methodology, a rapidly developing functional-imaging modality that has shown great promise in the fields of primary, recurrent and metastatic tumour detection, as well as in the planning and monitoring of the therapy of various tumours [19]. This evidence concerns the gene SLC2A1 and neoplasm.